The long-term objective of this proposal is to test the hypothesis that factors, which promote the expression or activity of DN-p63 contribute to the preservation of self-renewal in basal epithelia, and factors that oppose the expression or activity of DN-p63 contribute to the forfeiture of self-renewing capacity. There is abundant evidence that DN-p63 is required for the preservation of self-renewal, however the precise mechanisms by which it achieves this have not been fully elucidated. We define self-renewal as the ability to retain proliferative capacity, resist differentiation signals and avoid developmentally regulated apoptosis. Several recent studies have indicated that cancer initiation is a condition of unregulated self-renewal. This underscores the importance of identifying the mechanisms that preserve and regulate self-renewal and defining the consequences of their subversion.
Specific Aim 1 intends to evaluate the contributions of DNp63 to retention of proliferative capacity and resistance to cellular differentiation signals.
Specific Aim 2 intends to evaluate the contributions of DN-p63 to resistance to apoptosis, and the role of DN-p63 in mediating an appropriate response to genotoxic stress.
Specific Aim 3 intends to address the developmental consequences of forfeiture of self-renewal that is mediated by disruption of DN-p63. The goal of Specific Aim 3 is to identify and validate gene-regulatory events that result from disruption of DN-p63 and to determine if these events mediate the forfeiture of self-renewal. Our previous studies indicate that DNp63 is a direct target of p53, however genetic analysis of p53 has not indicated a self-renewal deficiency.
Specific Aim 4 intends to identify and characterize a p53-independent mechanism that promotes expression of DN-p63, and to determine if this mechanism is responsible for p53-independent expression of DN-p63. Successful completion of these aims will offer insights into the molecular mechanisms underlying the decision of self-renewing basal progenitors to either preserve or forfeit self-renewing capacity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA108539-05
Application #
7575824
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Watson, Joanna M
Project Start
2005-04-01
Project End
2010-08-28
Budget Start
2009-03-01
Budget End
2010-08-28
Support Year
5
Fiscal Year
2009
Total Cost
$228,179
Indirect Cost
Name
Dartmouth College
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
DeCastro, Andrew J; Cherukuri, Pratima; Balboni, Amanda et al. (2015) ?NP63? transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis. Mol Cancer Ther 14:225-35
Balboni, Amanda L; Cherukuri, Pratima; Ung, Matthew et al. (2015) p53 and ?Np63? Coregulate the Transcriptional and Cellular Response to TGF? and BMP Signals. Mol Cancer Res 13:732-42
DeCastro, A J; Dunphy, K A; Hutchinson, J et al. (2013) MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ?NP63? and promotes mesenchymal-to-epithelial transition. Cell Death Dis 4:e514
Balboni, Amanda L; Hutchinson, Justine A; DeCastro, Andrew J et al. (2013) ?Np63?-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells. Cancer Res 73:1020-30
Cherukuri, Pratima; DeCastro, Andrew J; Balboni, Amanda L et al. (2012) Phosphorylation of ?Np63? via a novel TGF?/ALK5 signaling mechanism mediates the anti-clonogenic effects of TGF?. PLoS One 7:e50066
Kent, Sierra; Hutchinson, Justine; Balboni, Amanda et al. (2011) ?Np63? promotes cellular quiescence via induction and activation of Notch3. Cell Cycle 10:3111-8
Harmes, David C; DiRenzo, James (2009) Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses? J Mammary Gland Biol Neoplasia 14:19-27
Li, Na; Singh, Samer; Cherukuri, Pratima et al. (2008) Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells. Stem Cells 26:1253-64
Li, Hua; Cherukuri, Pratima; Li, Na et al. (2007) Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 67:501-10
Li, N; Li, H; Cherukuri, P et al. (2006) TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53. Oncogene 25:2349-59